BR0208994A - Composição farmacêutica finamente auto-emulsificável - Google Patents
Composição farmacêutica finamente auto-emulsificávelInfo
- Publication number
- BR0208994A BR0208994A BR0208994-7A BR0208994A BR0208994A BR 0208994 A BR0208994 A BR 0208994A BR 0208994 A BR0208994 A BR 0208994A BR 0208994 A BR0208994 A BR 0208994A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- self
- drug
- fatty acid
- organic amine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- 150000001412 amines Chemical class 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA FINAMENTE AUTO-EMULSIFICáVEL". A presente invenção refere-se a uma composição farmacêutica administrável por via oral, compreendendo uma droga de baixa solubilidade em água e um líquido solvente que compreende pelo menos um solvente farmaceuticamente aceitável, pelo menos um ácido graxo farmaceuticamente aceitável e pelo menos uma amina orgânica farmaceuticamente aceitável, onde (a) uma porção substancial, por exemplo pelo menos cerca de 15% em peso, da droga está dissolvida ou solubilizada no líquido solvente, e (b) o ácido graxo e a amina orgânica estão presentes em quantidades totais e relativas tais que a composição é finamente auto-emulsificável em fluido gástrico simulado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28438101P | 2001-04-17 | 2001-04-17 | |
US32695201P | 2001-10-04 | 2001-10-04 | |
PCT/US2002/011689 WO2002083177A1 (en) | 2001-04-17 | 2002-04-12 | Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208994A true BR0208994A (pt) | 2004-04-27 |
Family
ID=26962574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208994-7A BR0208994A (pt) | 2001-04-17 | 2002-04-12 | Composição farmacêutica finamente auto-emulsificável |
Country Status (18)
Country | Link |
---|---|
US (1) | US20030105141A1 (pt) |
EP (1) | EP1379279A1 (pt) |
JP (1) | JP2004530669A (pt) |
KR (1) | KR20040018355A (pt) |
CN (1) | CN1516601A (pt) |
AR (1) | AR033221A1 (pt) |
AU (1) | AU2002305175B2 (pt) |
BR (1) | BR0208994A (pt) |
CA (1) | CA2444220A1 (pt) |
CZ (1) | CZ20032792A3 (pt) |
EA (1) | EA008103B1 (pt) |
IL (1) | IL158201A0 (pt) |
MX (1) | MXPA03009411A (pt) |
NO (1) | NO20034629L (pt) |
NZ (1) | NZ528741A (pt) |
PE (1) | PE20021145A1 (pt) |
PL (1) | PL364524A1 (pt) |
WO (1) | WO2002083177A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
EP1344523A1 (en) * | 2002-03-11 | 2003-09-17 | Warner-Lambert Company | Ibuprofen solution for hard gelatin capsules |
IL164163A0 (en) * | 2002-04-09 | 2005-12-18 | Pharmacia Corp | Process for preparing a finely self-emulsifiable pharmaceutical composition |
US20060141470A1 (en) * | 2003-02-14 | 2006-06-29 | Kalayoglu Murat V | Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
LT2279729T (lt) * | 2003-07-17 | 2016-10-10 | Banner Life Sciences, LLC | Kontroliuojamo atpalaidavimo preparatas |
EP1510206A1 (en) * | 2003-08-29 | 2005-03-02 | Novagali Pharma SA | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
WO2005123043A2 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
MX2007009888A (es) * | 2005-02-17 | 2007-10-16 | Synta Pharmaceuticals Corp | Compuestos para el tratamiento de trastornos proliferativos. |
US8293270B2 (en) | 2005-10-26 | 2012-10-23 | Banner Pharmacaps, Inc. | Lipophilic vehicle-based dual controlled release matrix system |
CN101360485B (zh) * | 2005-10-26 | 2013-04-17 | 班纳制药公司 | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 |
US8999381B2 (en) * | 2007-09-27 | 2015-04-07 | Wockhardt Ltd. | Self-emulsifying pharmaceutical compositions of rhein or diacerein |
EA020354B1 (ru) * | 2008-12-03 | 2014-10-30 | Астеллас Дойчланд Гмбх | Пероральные лекарственные формы бендамустина |
US9717703B2 (en) | 2009-10-16 | 2017-08-01 | Glaxosmithkline Llc | Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed |
JO3659B1 (ar) | 2010-06-02 | 2020-08-27 | Astellas Deutschland Gmbh | أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية |
EP2575784B1 (en) * | 2010-06-02 | 2018-08-08 | Astellas Deutschland GmbH | Oral dosage forms of bendamustine |
EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
ES2859676T3 (es) * | 2011-10-18 | 2021-10-04 | Askat Inc | Composición medicinal |
BR112015015858B1 (pt) * | 2013-01-14 | 2023-02-28 | Infirst Healthcare Limited | Uso de uma composição farmacêutica de solução sólida no tratamento de uma inflamação crônica |
WO2014117999A1 (en) * | 2013-02-04 | 2014-08-07 | Biocopea Limited | Compositions and methods for treating chronic inflammation and inflammatory diseases |
CN105491886B (zh) | 2013-08-27 | 2019-01-29 | V·沃道里斯 | 苯达莫司汀医药组合物 |
CN113750043A (zh) * | 2021-09-18 | 2021-12-07 | 山东省药学科学院 | 一种塞来昔布自乳化口服液及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2193609T3 (es) * | 1993-11-30 | 2003-11-01 | Searle & Co | Pirazolil-bencenosulfonamidas sustituidas y su uso como inhibidores de la ciclooxigenasa ii. |
US5571536A (en) * | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
US5733909A (en) * | 1996-02-01 | 1998-03-31 | Merck Frosst Canada, Inc. | Diphenyl stilbenes as prodrugs to COX-2 inhibitors |
BR9812018A (pt) * | 1997-08-27 | 2000-09-26 | Hexal Ag | Composições farmacêuticas de meloxicam com solubilidade e biodisponibilidade melhoradas |
US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
AR035642A1 (es) * | 2000-05-26 | 2004-06-23 | Pharmacia Corp | Uso de una composicion de celecoxib para el alivio rapido del dolor |
WO2002005799A2 (en) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
-
2002
- 2002-04-09 US US10/119,129 patent/US20030105141A1/en not_active Abandoned
- 2002-04-12 BR BR0208994-7A patent/BR0208994A/pt not_active IP Right Cessation
- 2002-04-12 EP EP02733979A patent/EP1379279A1/en not_active Withdrawn
- 2002-04-12 CN CNA028120787A patent/CN1516601A/zh active Pending
- 2002-04-12 JP JP2002580978A patent/JP2004530669A/ja not_active Withdrawn
- 2002-04-12 IL IL15820102A patent/IL158201A0/xx unknown
- 2002-04-12 PL PL02364524A patent/PL364524A1/xx not_active Application Discontinuation
- 2002-04-12 NZ NZ528741A patent/NZ528741A/en unknown
- 2002-04-12 EA EA200301019A patent/EA008103B1/ru not_active IP Right Cessation
- 2002-04-12 CA CA002444220A patent/CA2444220A1/en not_active Abandoned
- 2002-04-12 KR KR10-2003-7013651A patent/KR20040018355A/ko not_active Application Discontinuation
- 2002-04-12 WO PCT/US2002/011689 patent/WO2002083177A1/en active IP Right Grant
- 2002-04-12 AU AU2002305175A patent/AU2002305175B2/en not_active Ceased
- 2002-04-12 MX MXPA03009411A patent/MXPA03009411A/es not_active Application Discontinuation
- 2002-04-12 CZ CZ20032792A patent/CZ20032792A3/cs unknown
- 2002-04-16 PE PE2002000315A patent/PE20021145A1/es not_active Application Discontinuation
- 2002-04-17 AR ARP020101396A patent/AR033221A1/es unknown
-
2003
- 2003-10-16 NO NO20034629A patent/NO20034629L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004530669A (ja) | 2004-10-07 |
NO20034629L (no) | 2003-12-10 |
NZ528741A (en) | 2005-09-30 |
EA008103B1 (ru) | 2007-04-27 |
CA2444220A1 (en) | 2002-10-24 |
AR033221A1 (es) | 2003-12-10 |
NO20034629D0 (no) | 2003-10-16 |
EA200301019A1 (ru) | 2004-06-24 |
MXPA03009411A (es) | 2004-01-29 |
KR20040018355A (ko) | 2004-03-03 |
PL364524A1 (en) | 2004-12-13 |
CZ20032792A3 (cs) | 2004-04-14 |
CN1516601A (zh) | 2004-07-28 |
EP1379279A1 (en) | 2004-01-14 |
US20030105141A1 (en) | 2003-06-05 |
PE20021145A1 (es) | 2003-01-16 |
WO2002083177A1 (en) | 2002-10-24 |
AU2002305175B2 (en) | 2007-07-12 |
IL158201A0 (en) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0208994A (pt) | Composição farmacêutica finamente auto-emulsificável | |
BR0309138A (pt) | Processo para a preparação de uma composição farmacêutica finamente auto-emulsionável | |
BR0206580A (pt) | Composição farmacêutica tendo tendência reduzida para cristalização de droga | |
BRPI0412457A (pt) | composição farmacêutica para aumento da solubilidade de drogas hidrofóbicas | |
BR9814755A (pt) | Composto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais, e para o tratamento ou profilaxia de condições que envolvam infecção por helicobacter pylori da mucosa gástrica humana | |
BR0313060A (pt) | Composições farmacêuticas aquosas de 2,6-diisopropilfenol | |
MX9306303A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
AR020662A1 (es) | Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento. | |
CY1112523T1 (el) | Υγρες συνθεσεις κανναβινοειδων για χορηγηση σε βλεννογονο | |
EP1362846A4 (en) | AMINOETHANOLDERIVATE | |
BR0212864A (pt) | Derivados de 1,6-naftiridina como antidiabéticos | |
MX9307781A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
BR9810592A (pt) | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto | |
BRPI0906348A2 (pt) | composto representado pela fórmula (1), composição farmacêutica; inibidor pai-1 e medicamento para prevenção para prevenção e/ou tratamento terapêutico de doença causada pela manifestação de pai-1 ou pelo aumento da ação de pai-1 | |
BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
BR9807457A (pt) | Composto, sal de hidrocloreto, formulação farmacêutica, uso de um composto, e, processos para a preparação de um composto, para a inibição da secreção de ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais e para o tratamento ou profilaxia de condições que envolvem infecção por helicobacter pylori da mucosa gástrica humana. | |
NO20025629D0 (no) | Formulering | |
FI20000172A (fi) | Itse-emulgoituvan valmisteen muodossa oleva farmaseuttinen koostumus happamia lipoifiilisia yhdisteitä varten | |
BR0107958A (pt) | Composição farmacêutica contendo pemetrexado juntamente com l-cisteìna monotrioglicerol ou ácido tioglicólico | |
BR0109012A (pt) | Composição farmacêutica, forma de dosagem unitária, solução oral, método para o tratamento da dor, e, método para o tratamento de inflamações | |
MA29481B1 (fr) | Derives d'azolopyridine-2-one en tant qu'inhibiteurs de lipase et de phospholipase | |
BR0317523A (pt) | Processo para a preparação de formulações farmacêuticas de combinação utilizando fluidos supercrìticos | |
BR0008479A (pt) | Agonistas de 5-ht 1f | |
ATE270T1 (de) | Neue n1-benzoyl-n2-phenyl-1,3-diaminopropan-2-ole und ihre salze; verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |